Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
August 04, 2026
The Third Circuit has declined to revive a whistleblower suit by Olympus Corp.'s former employee who claimed he was fired after reporting FDA regulatory violations, ruling Tuesday that he failed to state a retaliation claim under the False Claims Act since he didn't link his concerns to a reasonable belief that Olympus defrauded the government.
-
August 04, 2026
Procter & Gamble is acquiring supplements company Thorne from L Catterton for $3.8 billion in cash, with Kirkland & Ellis LLP and Jones Day serving as legal advisers in the transaction, the companies announced Tuesday.
-
August 04, 2026
The co-founder of a defunct biotech company said his business partners froze him out of an asthma drug venture that was eventually snapped up by GlaxoSmithKline for $1.4 billion, in a complaint filed in Massachusetts state court.
-
August 04, 2026
Saxena White PA has asked a Connecticut federal court to appoint it as lead counsel in a securities class action accusing the biopharma company GeneDX Holdings Corp. of misrepresenting the benefits of a $51 million acquisition, and to name two public retirement systems as lead plaintiffs.
-
August 04, 2026
After the U.S. Supreme Court's recent Hikma v. Amarin decision putting a spotlight on the pleading standard for inducement, patent litigants must adapt to courts' differing approaches to how separate method steps affect the determination of patent venue validity, say attorneys at Weil.
See more Life Sciences news